Citadel Advisors
SGRX

Citadel Advisors’s SANGRIX INC. Class A Ordinary Shares SGRX Stock Holding History

Citadel Advisors’s Portfolio SGRX Stock Details SGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-672
Closed -$34.6K – 13041
2025
Q4 		$34.6K Buy
+672
New +$62.6K ﹤0.01% 12171
2025
Q1 		– Sell
-51
Closed -$14.9K – 14530
2024
Q4 		$14.9K Buy
+51
New +$24.6K ﹤0.01% 13384
2024
Q3 		– Sell
-114
Closed -$98.4K – 14283
2024
Q2 		$98.4K Buy
+114
New +$129K ﹤0.01% 10938
2023
Q2 		– Sell
-7
Closed -$16.5K – 14383
2023
Q1 		$16.5K Buy
7
+3
+75% +$6.99K ﹤0.01% 13196
2022
Q4 		$6.41K Buy
4
+1
+33% +$2.13K ﹤0.01% 13922
2022
Q3 		$12K Sell
3
-4
-57% -$14.2K ﹤0.01% 12220
2022
Q2 		$28K Buy
+7
New +$50K ﹤0.01% 12256
2021
Q4 		– Sell
-9
Closed -$84K – 13830
2021
Q3 		$84K Hold
9
– – ﹤0.01% 13027
2021
Q2 		$131K Sell
9
-7
-44% -$73.6K ﹤0.01% 12654
2021
Q1 		$153K Buy
+16
New +$156K ﹤0.01% 12000
2020
Q1 		– Sell
-1
Closed -$48K – 9609
2019
Q4 		$48K Sell
1
-1
-50% -$38K ﹤0.01% 8763
2019
Q3 		$101K Buy
+2
New +$84.2K ﹤0.01% 8477

Other funds holding SGRX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Citadel Advisors's SGRX Position: Q1 2026 in Review

Citadel Advisors sold out of SANGRIX INC. Class A Ordinary Shares (SGRX) in Q1 2026, closing a stake of 672 shares — an estimated $34.6K sold.

Citadel Advisors first reported a position in SGRX in Q3 2019 and held it in 12 quarters. The position peaked at $153K in Q1 2021. 4 funds tracked by Wall St. Rank hold SGRX as of Q1 2026.

  • Citadel Advisors reported no remaining SANGRIX INC. Class A Ordinary Shares position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 672 SANGRIX INC. Class A Ordinary Shares shares in Q1 2026, an estimated $34.6K.
  • Citadel Advisors first reported a position in SANGRIX INC. Class A Ordinary Shares in Q3 2019 and held it in 12 quarters.
  • Citadel Advisors's SANGRIX INC. Class A Ordinary Shares position peaked at $153K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held SANGRIX INC. Class A Ordinary Shares as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.